Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008–2012)
2020 · Lipids in Health and Disease · 82 citations
https://doi.org/10.1186/s12944-020-01211-z
F
Fen Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
228
Papers
3.9K
Citations
31
h-index
93
i10-index
Fen Liu is an academic researcher from South China Agricultural University. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & Circular RNAs in diseases. The author has an h-index of 31, co-authored 194 publications.
ORCID: 0009-0001-5216-3931Papers by this author
worksHBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA
2020 · Scientific Reports · 31 citations
https://doi.org/10.1038/s41598-020-57637-z
Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis
2019 · Scientific Reports · 30 citations
https://doi.org/10.1038/s41598-019-51982-4
A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma
2018 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-018-19949-z
Albumin infusion may decrease the mortality of hypoalbuminemia patients with severe acute pancreatitis: a retrospective cohort study
2023 · BMC Gastroenterology · 21 citations
https://doi.org/10.1186/s12876-023-02801-8
Immunization with DNA prime-subunit protein boost strategy based on influenza H9N2 virus conserved matrix protein M1 and its epitope screening
2020 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-020-60783-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat